PDS Biotech Sets Q1 2026 Earnings Release for May 13
PDS Biotechnology will report Q1 2026 results before market open, with a consensus EPS estimate of -$0.14 and $0M revenue. PDS Biotechnology (PDSB) will announce its Q1 2026 earnings on Wednesday, May 13, ahead of the market opening. Analysts expect a loss of $0.14 per sha